{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:41:12Z","timestamp":1784169672166,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.141388","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:57:30Z","timestamp":1740139050000},"page":"141388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["QbD-based formulation development and evaluation of lipid-cellulose-based extended-release multi-particulates of cinitapride and its in-silico PBPK modeling"],"prefix":"10.1016","volume":"306","author":[{"given":"Muhammad Umair","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faaiza","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Iqbal","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia Ismail","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sikandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141388_bb0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141388_bb0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/10837450.2014.908300","article-title":"Application of quality by design (QbD) to formulation and processing of naproxen pellets by extrusion\u2013spheronization","volume":"20","author":"Wang","year":"2015","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2478\/acph-2019-0007","article-title":"Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion\/spheronization pellet formulations","volume":"69","author":"Barbosa","year":"2019","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0020","article-title":"Liquisolid pellets: mixture experimental design assessment of critical quality attributes influencing the manufacturing performance via extrusion-spheronization","volume":"57","author":"dos Santos Fonseca","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0025","first-page":"11","article-title":"Formulation and optimization of pellets containing Zaltoprofen by extrusion spheronization","volume":"11","author":"Patel","year":"2024","journal-title":"Nirma Univ. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0030","series-title":"Pharmaceutical PelletizationTechnology Pellets: A General Overview","author":"Ghebre-Selassie","year":"1989"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141388_bb0035","first-page":"331","article-title":"Different aspects of pellets formulation and their evaluation","volume":"4","author":"Gupta","year":"2015","journal-title":"International Journal of Pharmaceutical and Phytopharmacological Research"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141388_bb0040","article-title":"Pelletization Techniques: A review","volume":"10","author":"Vyas","year":"2019","journal-title":"International Journal of Pharmacy & Life Sciences"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0466-x","article-title":"Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent\u2014meclizine HCl","volume":"16","author":"Qazi","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.15212\/bioi-2024-0079","article-title":"Multiparticulate drug delivery of losartan potassium via extrusion-spheronization: formulation and dissolution comparisons","volume":"5","author":"Yadav","year":"2024","journal-title":"BIO Integration"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0055","series-title":"Studies on Almond Gum and Gelucire-Based Pellets Prepared by Extrusion and Spheronization for Sustained Release","first-page":"521","volume":"19(5)","author":"Kanteti","year":"2022"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0060","article-title":"Premium ethylcellulose polymer based architectures at work in drug delivery","volume":"1","author":"Adeleke","year":"2019","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.141388_bb0065","article-title":"Ethylcellulose-A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development","volume":"12","author":"Wasilewska","year":"2019","journal-title":"Materials (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0070","series-title":"Ethocel Ethylcellulose polymers technical handbook","first-page":"1","author":"Cellulosics","year":"2005"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141388_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/DDC-120002445","article-title":"Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method","volume":"28","author":"Iqbal","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/03639049509048096","article-title":"Ethylcellulose-a polymer review","volume":"21","author":"Rekhi","year":"1995","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0085","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1038\/s41598-020-71751-y","article-title":"QbD based Eudragit coated meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-fluorescence detection method","volume":"10","author":"Qazi","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12944-018-0783-8","article-title":"Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded\/spheronized, sintered and compacted pellets","volume":"17","author":"Maboos","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10837450903013576","article-title":"An oral controlled release system for amroxol hydrochloride containing a wax and a water insoluble polymer","volume":"15","author":"Chi","year":"2010","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0100","author":"F"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.foodres.2018.11.013","article-title":"Role of the oil on glyceryl monostearate based oleogels","volume":"120","author":"Ferro","year":"2019","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0110","series-title":"Handbook of Pharmaceutical Excipients","author":"Kibbe","year":"2000"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2008.04.001","article-title":"Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique: II. In vitro drug release studies and release mechanisms","volume":"359","author":"Cheboyina","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141388_bb0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jps.23830","article-title":"Design of Lipid Matrix Particles for Fenofibrate: effect of polymorphism of glycerol Monostearate on drug incorporation and release","volume":"103","author":"Xia","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0466-x","article-title":"Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent\u2014meclizine HCl","volume":"16","author":"Qazi","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0783-8","article-title":"Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded\/spheronized, sintered and compacted pellets","volume":"17","author":"Maboos","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.141388_bb0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1124\/dmd.106.010835","article-title":"The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole","volume":"35","author":"Robert","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/HC.2005.11.1.23","article-title":"Synthesis and biological evaluation of cinitapride related derivatives as potential prokinetic agents","volume":"11","author":"Srinivasulu","year":"2005","journal-title":"Heterocycl. Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141388_bb0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4155\/bio-2016-0210","article-title":"Development of an UPLC\u2013MS\/MS micromethod for quantitation of cinitapride in plasma and its application in a pharmacokinetic interaction trial","volume":"9","author":"Marcel\u00edn-Jim\u00e9nez","year":"2017","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141388_bb0150","first-page":"747","article-title":"Efficacy and safety of cinitapride in functional dyspepsia","volume":"63","author":"Baqai","year":"2013","journal-title":"JPMA. J. Pak. Med. Assoc."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0155","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s11998-019-00211-8","article-title":"Formulation development and characterization of highly water-soluble drug-loaded extended-release pellets prepared by extrusion\u2013spheronization technique","volume":"16","author":"Nasiri","year":"2019","journal-title":"J. Coat. Technol. Res."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0160","article-title":"Effects of superdisintegrants in oral dissolving formulation of cinitapride tablets","volume":"31","author":"Bushra","year":"2018","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0165","series-title":"The United States Pharmacopeia: The National Formulary","author":"C. USP","year":"2012"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1155\/2011\/614160","article-title":"Development and validation of a rapid RP HPLC method for the determination of cinitapride hydrogen tartarate in solid oral dosage forms","volume":"8","author":"Humaira","year":"2011","journal-title":"J. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0180","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.2147\/IJN.S367540","article-title":"Nanoclay-based composite films for transdermal drug delivery: development, characterization, and in silico modeling and simulation","author":"Sikandar","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133841","article-title":"Cellulose ether and carbopol 971 based gastroretentive controlled release formulation design, optimization and physiologically based pharmacokinetic modeling of ondansetron hydrochloride minitablets","volume":"276","author":"Maqbool","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141388_bb0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/pt0803074","article-title":"Sintering of wax for controlling release from pellets","volume":"8","author":"Singh","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0195","unstructured":"USP29-NF-24, Physical Test and Determinations <616> Bulk Density and Tapped density of Powders."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.141388_bb0200","first-page":"4737","article-title":"Formulation and evaluation of fast disintegrating oral thin films of cinitapride hydrogen tartarate","volume":"6","author":"Chinnala","year":"2017","journal-title":"International Journal of Current Advanced Research"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0205","first-page":"9","article-title":"Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization","volume":"20","author":"Garekani","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.141388_bb0210","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/03639040903520967","article-title":"Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability","volume":"36","author":"Wang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.141388_bb0215","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpba.2005.02.037","article-title":"Guidelines from the international conference on harmonisation (ICH)","volume":"38","author":"Branch","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.141388_bb0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2015.04.021","article-title":"Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs","volume":"488","author":"Gaber","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0225","doi-asserted-by":"crossref","first-page":"1066018","DOI":"10.3389\/fphar.2023.1066018","article-title":"SeDeM expert system with I-optimal mixture design for oral multiparticulate drug delivery: an encapsulated floating minitablets of loxoprofen Na and its in silico physiologically based pharmacokinetic modeling","volume":"14","author":"Shoaib","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0230","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijbiomac.2016.12.052","article-title":"In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model","volume":"96","author":"Kumar","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0235","unstructured":"D. Online, Cinitapride. https:\/\/go.drugbank.com\/drugs\/DB08810."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0240","first-page":"1","article-title":"Pharmacokinetics and tolerability of Cinitapride in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study","volume":"49","author":"Zhang","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0245","series-title":"The preparation by extrusion\/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate","first-page":"35","volume":"24(1)","author":"Chatchawalsaisin","year":"2005"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0250","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejps.2016.01.021","article-title":"Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools","volume":"84","author":"Gurram","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0255","series-title":"Studies on the Influence of Composition and Processing on the Mechanical Properties of Pellets and Compacted Pellets, University of London, University College London (United Kingdom)","author":"Bashaiwoldu","year":"2002"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0260","series-title":"Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods, Specification of Drug Substances and Products","first-page":"29","author":"Lloyd","year":"2014"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/9780470640487.ch17","article-title":"Oral controlled drug delivery: quality by design (QbD) approach to drug development","author":"Singh","year":"2010","journal-title":"Oral controlled release formulation design and drug delivery: theory to practice"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.powtec.2018.08.002","article-title":"Effects of pharmaceutical processes on the quality of ethylcellulose coated pellets: quality by design approach","volume":"339","author":"Thapa","year":"2018","journal-title":"Powder Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cep.2009.12.002","article-title":"Optimization of preparation of matrix pellets containing ethylcellulose","volume":"49","author":"Hamedelniel","year":"2010","journal-title":"Chem. Eng. Process. Process Intensif."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.141388_bb0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ajps.2016.08.001","article-title":"Extrusion\u2013spheronization a promising pelletization technique: in-depth review","volume":"11","author":"Muley","year":"2016","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.141388_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(01)00908-5","article-title":"Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization","volume":"232","author":"Sousa","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101902","article-title":"Optimized flurbiprofen sustained-release matrix pellets prepared by extrusion\/spheronization","volume":"59","author":"Alshora","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ddtec.2018.06.009","article-title":"Matrix systems for oral drug delivery: formulations and drug release","volume":"27","author":"Vasv\u00e1ri","year":"2018","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03639040500388482","article-title":"Directly compressed Mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release","volume":"32","author":"Lopes","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.141388_bb0305","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1208\/ps050213","article-title":"Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release","volume":"5","author":"Agrawal","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0310","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00137696-200402010-00003","article-title":"Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems","volume":"2","author":"Varma","year":"2004","journal-title":"Am. J. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1081\/DDC-100102141","article-title":"Influence of process variables on physical properties of the pellets using extruder and spheronizer","volume":"25","author":"Umprayn","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.141388_bb0320","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1295\/1\/012063","article-title":"Modelling of controlled drug release in gastrointestinal tract simulation","volume":"1295","author":"Permanadewi","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0325","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.2147\/DDDT.S278918","article-title":"Quality by design (QbD)-based numerical and graphical optimization technique for the development of osmotic pump controlled-release metoclopramide HCl tablets","author":"Farooqi","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0330","article-title":"Preparation and evaluation of lipid-based sustained release pellets of chlorpheniramine maleate by the wet extrusion-spheronization method","volume":"15","author":"Abbaspour","year":"2024","journal-title":"BioImpacts"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0335","series-title":"The preparation of spherical granules by extrusion\/spheronization without microcrystalline cellulose","volume":"16(10)","author":"Podczeck","year":"2004"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.141388_bb0340","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3109\/03639049509069244","article-title":"Development and in vitro evaluation of a novel multiparticulate matrix controlled release formulation of theophylline","volume":"21","author":"Peh","year":"1995","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.141388_bb0345","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1081\/DDC-100101252","article-title":"Possible mechanism for drug retardation from glyceryl monostearate matrix system","volume":"26","author":"Peh","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0350","series-title":"Asymmetric membrane tablet coatings for controlled-release of drugs, Izmir Institute of Technology (Turkey)","author":"Yenal","year":"2002"},{"key":"10.1016\/j.ijbiomac.2025.141388_bb0355","first-page":"141","article-title":"Study of differential scanning calorimetry of atorvastatin in solid solution","volume":"14","author":"Dewan","year":"2011","journal-title":"Bangladesh Pharm. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.141388_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/00498254.2018.1447710","article-title":"Pharmacokinetics and tolerability of cinitapride in healthy Chinese volunteers: a randomized, open-label, single-and multiple-dose study","volume":"49","author":"Zhang","year":"2019","journal-title":"Xenobiotica"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025019397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025019397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:44:28Z","timestamp":1782902668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025019397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":72,"alternative-id":["S0141813025019397"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141388","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QbD-based formulation development and evaluation of lipid-cellulose-based extended-release multi-particulates of cinitapride and its in-silico PBPK modeling","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141388"}}